Hadi Danaee

Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

Ana Oaknin, Anna V. Tinker, Lucy Gilbert et al. · JAMA Oncology · 2020 · 357 citations · Full text

Medicine, Oncology, Pharmacology +16

Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation.

Charles W. Frevert, Siyi Huang, Hadi Danaee et al. · The Journal of Immunology · 1995 · 238 citations

Life Sciences, Immunology, Pathology +17

Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

Jonathan W. Friedberg, Daruka Mahadevan, Erin Cebula et al. · Journal of Clinical Oncology · 2013 · 209 citations · Full text

Medicine, Hematology, Pharmacology +17

Carcinogen exposure and gene promoter hypermethylation in bladder cancer

Carmen J. Marsit, Margaret R. Karagas, Hadi Danaee et al. · Carcinogenesis · 2005 · 193 citations · Full text

Medicine, Molecular Biology, Oncology +17

Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

Ursula A. Matulonis, Sudarshan Sharma, Michael S. Gordon et al. · Gynecologic Oncology · 2012 · 134 citations

Medicine, Oncology, Pharmacology +16